Yemaachi Biotech
Accra precision oncology company building the African Cancer Atlas, a genetically diverse pan-African cancer genomics database used to develop diagnostics and therapeutics that perform across populations; it also provides genomics research services with partners across the continent.
Headquarters
Accra, Ghana
Year Founded
2020
Founders
Yaw Bediako (CEO), David Hutchful, Joyce Ngoi, Yaw Attua-Afari
Country
Ghana
Financial Information
Funding Stage
Seed
Recent Funding
$3M
Funding By
V8 Capital, LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital
Core Technology
African cancer genomics database and precision-oncology diagnostics
Product Type
Diagnostic
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
Not disclosed
Academic / Hospital Tie-ups
Cancer Grand Challenges Team SAMBAI (up to $25M over five years); African research hospitals
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Largest pan-African cancer genomics dataset, countering European-ancestry bias in oncology data